Elucidation of the mechanisms underlying drug resistance of oral cancer based on microRNA analysis and applications of the findings to novel diagnostic and therapeutic strategy
Project/Area Number |
23592967
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Kumamoto University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
SHINOHARA Masanori 熊本大学, 生命科学研究部, 教授 (90117127)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | マイクロRNA / 薬剤耐性 / 口腔癌 / microRNA / miR-30a / 口腔扁平上皮癌細胞 / 5-FU耐性 / サイクリンE2 |
Research Abstract |
Five-FU-resistant oral squamous cell carcinoma cell lines expressed more miR-30a than the parent cells, thus resulting in increased G1-arrested cells. Luciferase assay revealed that miR-30a suppresses the translation of cyclin E2. MiR-30a targeting significantly increased the sensitivity to 5-FU of OSCC cells with upregulation of cyclin E2 and downregulation of G1-arrested cells. These results suggest that miR-30a could be a useful target for overcoming 5-FU resistance of OSCC.
|
Report
(4 results)
Research Products
(26 results)
-
[Journal Article] A low Dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma.2014
Author(s)
Kawahara K*, Nakayama H*, Nagata M, Yoshida R, Hirosue A, Tanaka T, Nakagawa Y, Matsuoka Y, Kojima T, Takamune Y, Yoshitake Y, Hiraki A, and Shinohara M. (* Contributed equally)
-
Journal Title
J Oral Pathol Med.
Volume: 43
Issue: 5
Pages: 350-6
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Overexpression of fibronectin confers cell adhesion‑mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.2014
Author(s)
Nakagawa Y*, Nakayama H*, Nagata M, Yoshida R, Kawahara K, Hirosue A, Tanaka T, Yuno A, Matsuoka Y, Kojima T, Yoshitake Y, Hiraki A, and Shinohara M. (* Contributed equally)
-
Journal Title
Int J Oncol.
Volume: 44
Issue: 4
Pages: 1376-84
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Stromal Expression of Neutrophil Gelatinase-Associated Lipocalin Correlates with Poor Differentiation and Adverse Prognosis in Oral Squamous Cell Carcinoma2014
Author(s)
Shinriki S, Jono H, Ueda M, Obayashi K, Nakamura T, Ota K, Ota T, Sueyoshi T, Guo J, Hayashi M, Hiraki A, Nakayama H, Yamashita S, Shinohara M, Ando Y
-
Journal Title
Histopathology
Volume: 64(3)
Pages: 356-64
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Histopathological changes in parotid and submandibular glands of patients treated with preoperative chemoradiation therapy for oral cancer2012
Author(s)
Teshima K, Murakami R, Yoshida R, Nakayama H, Hiraki A, Hirai T, Nakaguchi Y, Tsujita N, Tomitaka E, Furusawa M, Yamashita Y, Shinohara M
-
Journal Title
J Radiat Res
Volume: 53(3)
Pages: 492-6
NAID
Related Report
Peer Reviewed
-
[Journal Article] Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma2012
Author(s)
Tanaka T, Nakayama H, Yoshitake Y, Irie A, Nagata M, Kawahara K, Takamune Y, Yoshida R, Nakagawa Y, Ogi H, Shinriki S, Ota K, Hiraki A, Ikebe T, Nishimura Y, Shinohara M
-
Journal Title
Cancer Sci
Volume: 103(3)
Pages: 455-63
Related Report
Peer Reviewed
-
[Journal Article] Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma.2012
Author(s)
Tanaka T, Nakayama H, Yoshitake Y, Irie A, Nagata M, Kawahara K, Takamune Y, Yoshida R, Nakagawa Y, Ogi H, Shinriki S, Ota K, Hiraki A, Ikebe T, Nishimura Y, Shinohara M.
-
Journal Title
Cancer Sci.
Volume: 103
Pages: 455-63
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma.2011
Author(s)
Nagata M, Nakayama H, Tanaka T, Yoshida R, Yoshitake Y, Fukuma D, Kawahara K, Nakagawa Y, Ota K, Hiraki A, Shinohara M.
-
Journal Title
Br J Cancer.
Volume: 105
Issue: 9
Pages: 1322-30
DOI
Related Report
Peer Reviewed
-
[Presentation] Overexpression of miR-30a confers 5-FU resistance by inhibiting cell proliferation via G1 phase arrest through targeting cyclin E2 in oral squamous cell carcinoma2013
Author(s)
Kenta Kawahara, Hideki Nakayama, Masashi Nagata, Ryoji Yoshida, Takuya Tanaka, Yoshihiro Nakagawa, Akiyuki Hirosue, Yuichiro Matsuoka, Yoshihiro Yoshitake, Akimitsu Hiraki, and Masanori Shinohara
Organizer
第72回日本癌学会学術総会
Place of Presentation
横浜
Year and Date
2013-10-05
Related Report
-
[Presentation] Overexpressed fibronectin contributes to cell adhesion-mediated drug resistance in oral squamous cell carcinoma2013
Author(s)
Yoshihiro Nakagawa, Hideki Nakayama, Ryoji Yoshida, Masashi Nagata, Kenta Kawahara, Takuya Tanaka, Akiyuki Hirosue, Yuichiro Matsuoka, Yasuo Takamune, Yoshihiro Yoshitake, Akimitsu Hiraki, and Masanori Shinohara
Organizer
第72回日本癌学会学術総会
Place of Presentation
横浜
Year and Date
2013-10-03
Related Report
-
-
[Presentation] Overexpression of miR-30a confers 5-FU resistance by inhibiting cell proliferation via G1 phase arrest through targeting cyclin E2 in oral squamous cell carcinoma2013
Author(s)
Kenta Kawahara, Hideki Nakayama, Masashi Nagata, Ryoji Yoshida, Takuya Tanaka, Yoshihiro Nakagawa, Akiyuki Hirosue, Yuichiro Matsuoka, Yoshihiro Yoshitake, Akimitsu Hiraki, and Masanori Shinohara
Organizer
第72回日本癌学会学術総会
Place of Presentation
パシフィコ横浜
Related Report
-
[Presentation] Overexpressed fibronectin contributes to cell adhesion-mediated drug resistance in oral squamous cell carcinoma2013
Author(s)
Yoshihiro Nakagawa, Hideki Nakayama, Ryoji Yoshida, Masashi Nagata, Kenta Kawahara, Takuya Tanaka, Akiyuki Hirosue, Yuichiro Matsuoka, Yasuo Takamune, Yoshihiro Yoshitake, Akimitsu Hiraki, and Masanori Shinohara
Organizer
第72回日本癌学会学術総会
Place of Presentation
パシフィコ横浜
Related Report
-
[Presentation] Preoperative Chemoradiotherapy with S-1 Followed by Surgery in Patient with Locally advanced Oral Squamous Cell Carcinoma: A Prospective Phase II Trial2012
Author(s)
Nakayama H, Nagata M, Tanaka T, Kawahara K, Nakagawa Y, Yoshida R, Ota Y, Hirosue A, Ogi H, FukumaD, Nanba A, Yoshitake Y, Ota K, Hiraki A, and Shinohara M.
Organizer
第51回大韓口腔顎顔面外科学会
Place of Presentation
江原道竜平リゾートグリーンピアコンドミニアム、ヨンピョン(韓国)
Related Report
-
[Presentation] Upregulation of miR-30a contributes to 5-FU resistance in oral squamous cell carcinoma2012
Author(s)
Kawahara K, Nakayama H, Nagata M, Yoshida R, Tanaka T, Nakagawa Y, Hirosue A, Ogi H, Fukuma D, Yoshitake Y, Ota K, Hiraki A, and Shinohara M.
Organizer
第71回日本癌学会
Place of Presentation
ロイトン札幌・さっぽろ芸文館・札幌市教育文化会館、札幌市
Related Report
-
[Presentation] The antiapoptotic mechanism underlying drug resistance of oral squamous cell carcinoma2012
Author(s)
Nakayama H, Nagata M, Kawahara K, Nakagawa Y, Yoshida R, Tanaka T, Hirosue A, Fukuma D, Ogi H, Yoshitake Y, Ota K, Hiraki A, and Shinohara M.
Organizer
17th World Congress on Advances in Oncology and 15th International Symposium on Molecular Medicine
Place of Presentation
Creta Marisホテル、クレタ島(ギリシャ)
Related Report
-
-
-
-